Dr. Mark DiBuono, MD
Claim this profileRichmond Behavioral Associates
Studies Alzheimer's Disease
Studies Dementia
10 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Mark DiBuono, MD is currently running
ML-004
for Autism Spectrum Disorder
This trial is testing a treatment called ML-004 to see if it can help improve social communication skills in adolescents and adults with Autism Spectrum Disorder (ASD). The study will involve about 150 participants to determine its effectiveness.
Recruiting0 awards Phase 21 criteria
Masupirdine
for Agitation in Alzheimer's Disease
This trial will test a medication called masupirdine, which participants will take regularly. It targets people with Alzheimer's disease who are experiencing agitation. The study aims to see if masupirdine can help reduce agitation and ensure it is safe and well-tolerated. Masupirdine has been previously evaluated in patients with moderate Alzheimer's disease and was found to be generally safe and well-tolerated.
Recruiting1 award Phase 32 criteria
More about Mark DiBuono, MD
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mark DiBuono, MD has experience with
- Placebo
- ML-004
- Masupirdine
- Engensis
- ATH-1017
- Simufilam
Breakdown of trials Mark DiBuono, MD has run
Alzheimer's Disease
Dementia
Alzheimer's Dementia
SHOX Deficiency Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark DiBuono, MD specialize in?
Mark DiBuono, MD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved APOE ε4 positive patients, or patients who are undergoing treatment.
Is Mark DiBuono, MD currently recruiting for clinical trials?
Yes, Mark DiBuono, MD is currently recruiting for 2 clinical trials in Staten Island New York. If you're interested in participating, you should apply.
Are there any treatments that Mark DiBuono, MD has studied deeply?
Yes, Mark DiBuono, MD has studied treatments such as Placebo, ML-004, Masupirdine.
What is the best way to schedule an appointment with Mark DiBuono, MD?
Apply for one of the trials that Mark DiBuono, MD is conducting.
What is the office address of Mark DiBuono, MD?
The office of Mark DiBuono, MD is located at: Richmond Behavioral Associates, Staten Island, New York 10314 United States. This is the address for their practice at the Richmond Behavioral Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.